Today, a large number of experts in the field of biomedicine from all over the world gather at the headquarters of Future Technology Group.

"In the past, I rarely involved in pharmaceutical biotechnology, but in my group's thousands of laboratories, more than a quarter of the laboratories are dedicated to biomedicine, human health and microbial genes as the main research field, four years, thousands of experts and scholars in my group, in this field finally achieved the first step of research results."

In the face of thousands of experts and scholars from all over the world in the venue, as well as countless media reporters, Cai Ruichen showed his young and confident style, focused on the flash, and said seriously and seriously:

"Precision medicine program, Europe, the United States, a large number of large countries and developing countries in Asia, have all conducted a lot of in-depth research in this field, the reason is very simple, the human body is different for everyone, and at present, all the drugs used by human beings to treat various diseases are universal, which also makes all the drugs can only be adapted to most of the population, some people have different physiques, although they are the same drugs, but they may not be able to play a role.

This is the reason why countries have started to carry out precision medicine programs, and the starting point of biomedical technology in the future is similar, but there is a difference, our research field is specifically aimed at the two major medical problems in the world, one is cancer, and the other is AIDS.

Taking cancer as an example, at present, human medical technology divides cancer into three categories, namely 'small cell carcinoma', 'squamous cell carcinoma' and 'adenocarcinoma', but this classification is of little significance to the process of cancer treatment.

If the patient has non-small cell carcinoma. The doctor can only choose to use a regimen that is less than 10% effective, and the patient will also suffer serious adverse reactions, but if it can be passed by genomics and proteology. Research on clinical markers and other aspects, do a good job of clinical response data at all times, make a more accurate diagnosis for patients, and then formulate specific and precise treatment plans based on clinical manifestations, and evaluate and familiarize themselves with analysis at all times, and accurately adjust the treatment plan. Adverse reactions of drugs can be avoided according to the patient's control of the condition or the alleviation of clinical adverse manifestations.

Precision medical technology is a medical revolution that is recognized worldwide. There is no doubt about it.

In this area of research, we invested more than $4 billion in research over a four-year period, and the results are all the clinical data collected by the future hospital over the course of five years. Receive human health data from all machine managers around the world. The world's largest human health data center was established to conduct research.

And here, I would like to thank all the robot stewards around the world and all the medical institutions around the world for authorizing the data collection work of the robot stewards to bring great help to our research.

In the past four years, our biomedical company has not produced any drugs, and only a few sets of practical auxiliary medical testing equipment have been sold in the global medical field.

It's not that we haven't been able to produce and develop those ordinary drugs. For those drugs that have a cure rate of more than 95 percent, these are not our goals.

The goal of future biomedical technology company research. It's all about drugs that have a cure rate of no more than 60 percent.

Because these fields are all global hot medical problems, including rheumatism, stroke and other medical problems, plus cancer and AIDS and other diseases, combined with the big data of human health problems, and through microbial gene research, the most effective and practical treatment and detection technology for difficult diseases in the biomedical field has been obtained so far.

I'm afraid not many people know that there are two genomes in the human body, one is the genes inherited by the parents, there are only 25,000 genes, these genes are the elite before the baby is born, and there is another set of genes that enter the human body after birth, especially the human intestine as many as 1,000 kinds of symbiotic microorganisms, the sum of its genetic information is called the microbiome, also known as the metagenome, it contains more than one million genomes, and the health of the human body, Only when these two genomes are in harmony with each other will there be guarantees.

In fact, all diseases in the human body can be found in the metagenome in the early stage or even before. ”

Speaking of this, Cai Ruichen paused, and looked at the huge science and technology venue, all of which were silent, and a pair of serious eyes were all staring at him.

He continued with a pause: "As we all know, the human health scan owned by the robot manager can detect the information of human diseases in a timely manner, and its accuracy has reached the level of 99.5%, and this is the technology of the group four years ago.

The first technology is human safety technology, which will also be implemented in the robot butler, a new and upgraded version of the robot butler, which will have the ability to detect cancer cells, and after up to a year of testing, the accuracy of the detection can be determined to be 100%.

This detection ability can accurately detect the signs of cell carcinogenesis before cancer cells appear in the human body, ensuring that the human body can be detected and contained before cancer cells actually appear.

For the specific details, Mr. Lin Chongxian will give you a detailed introduction at the next new product launch conference of Machine Steward.

Today, as the first scientific product launch of the future biomedical technology, we will announce to the world that the complete information of cancer will be available, and the probability of treatment will exceed 95%. ”

When Cai Ruichen finally said this, the whole venue was in an uproar, and at present, all countries and biomedical companies in the world have not yet completely treated cancer.

The United States, which has the most advanced medical treatment, is at most reducing the mortality rate by 20 percent and extending the treatment period by five years.

Cancer red blood cells are still one of the biggest problems plaguing human health.

Originally, everyone thought it was just a tech show, but the result was much more than everyone expected.

In the middle of the venue, a white-haired white scholar sitting in the front row stood up excitedly and asked Cai Ruichen, "Dr. Cai, can you explain the principle of treatment?"

At this moment, everyone in the venue, including all the cameras of the reporters, were all aimed at this scholar, and turned their eyes to Cai Ruichen, hoping that Cai Ruichen could answer.

The cure rate of drugs for cancer is as high as 95 percent, which will be the biggest medical breakthrough of the 21 st century. (To be continued.) )